These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 28975989)

  • 1. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
    Qiu W; Yang Z; Fan Y; Zheng Q
    Oncotarget; 2016 Jun; 7(26):39907-39915. PubMed ID: 27223438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
    Sun Y; Shi T; Ma Y; Qin H; Li K
    Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
    Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W
    Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
    Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
    Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression.
    Wei H; Pan L; Tao D; Li R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):56-61. PubMed ID: 29842886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
    Cao XZ; Bin H; Zang ZN
    Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD.
    Zhu J; Zhang Q; Jin XY; Cai JB; Chen X; Shi WB; Pang WY; Guo GL; Yang LJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2856-2862. PubMed ID: 31002136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA LINC00460 promotes carcinogenesis via sponging miR-613 in papillary thyroid carcinoma.
    Feng L; Yang B; Tang XD
    J Cell Physiol; 2019 Jul; 234(7):11431-11439. PubMed ID: 30478856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
    Guo K; Wang J; Shu L; Zhou G
    Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
    Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.